Elizabeth McKenna

@elizsmckenna.bsky.social

Executive Editor of Cancer Discovery, published by AACR. Harvard BBS/Dana-Farber alum. Native New Yorker. Posts are my own. She/her https://aacrjournals.org/cancerdiscovery

Now in Cancer Discovery: two studies showing that CDK8 inhibitors act by trapping Mediator on chromatin & that cancers w/driver oncogenes acting as dosage-sensitive transcription factors (e.g. aRMS, Ewing sarcoma) are vulnerable to impairment of transcriptional regulatory complex dynamics:

BildBild

In case you missed this Cancer Discovery paper in the news last week: First-in-Human Testing of a Mutant KRAS Vaccine for Pancreatic Cancer Interception in High-Risk Cohorts - by Daniel Haldar, Amanda Huff, Michael Goggins, Elizabeth Jaffee, Neeha Zaidi, and colleagues @aacrjournals.bsky.social

BildBild
American Association for Cancer Research (AACR)@theaacr.bsky.social · 4w ago

A vaccine to intercept pancreatic cancer in high-risk individuals was safe and elicited specific and durable immune responses, according to research published in the AACR journal Cancer Discovery. Learn more: www.aacr.org/about-the-aa...

Hear from cancer vaccine expert and Editor-in-Chief of Cancer Immunology Research Elizabeth M. Jaffee, MD, FAACR, on the latest breakthroughs, the clinical progress, and the path toward new effective vaccine-based strategies.

American Association for Cancer Research (AACR)@theaacr.bsky.social · 4w ago

Beyond therapy, research on vaccines for pancreatic cancer is exploring their application for cancer interception. Learn more about this and other recent advances on the #AACRBlog:

It's been a pleasure to work with Dr. Vander Heiden so far and I look forward to the next era of Cancer Discovery under his leadership! Luis Diaz, Tali Lev, Lisa Situ, Robert Kruger, and I joined him for our first team meeting at #AACR26 (Michele Hartsough and I-Mei Siu were holding down the fort)

Bild
American Association for Cancer Research (AACR)@theaacr.bsky.social · last mo.

AACR is pleased to announce that Matthew Vander Heiden, MD, PhD, FAACR, has been appointed editor-in-chief of the AACR journal Cancer Discovery. He joins Luis A. Diaz, Jr., MD, FAACR, in guiding this premier publication. Learn more: www.aacr.org/about-the-aa... #AACRFellows @aacrjournals.bsky.social